OPKO Health, Inc.

OPKO Health, Inc. is a renowned healthcare company founded in 2007 with 2329 employees, based in Miami, Florida, United States. Specializing in Pharmaceutical and Diagnostic Products, Medical Devices, Life Sciences, and B2C, the company has revenue of less than $5 million. OPKO Health, Inc. aims to improve patient lives through comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions.

At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. The entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs. We are proud of our first in class products, Rayaldee® (calcifediol), and the 4Kscore® test, as well as our diagnostics division, BioReference Laboratories and GeneDx. In addition to our clinical products and diagnostics, we have a robust research and development pipeline and a variety of biomedical and pharmaceutical business solutions. Since our founding in 2007, OPKO has grown into a global healthcare company, with over 5500 employees spanning nine countries, through organic growth and complementary acquisitions. More information available at www.opko.com.

Social

OPKO Health, Inc. is a diverse healthcare company focused on improving patient lives. They offer first-in-class products, comprehensive diagnostics laboratories, robust research and development pipelines, and unique pharmaceutical business solutions. The company also provides news updates, announcements, and investor relations on their websit